Helptext
More News

Latest News

DateTimeSubject
4/25/201310:22 AMIDL Biotech: Kallelse till årsstämma i IDL Biotech AB (publ)
4/25/201310:14 AMIDL Biotech: Delårsrapport kvartal 1 2013
3/21/20138:26 AMIDL Biotech: Positive results for UBC® Rapid in Clinical study

Graph with closing prices (blue curve) and volumes (red bars)

The graph has been adjusted for splits, reverse splits, issues and dividends
Graph for IDL Biotech B
 
Choose Date Horizon > 3 years 3 years 1 year 3 months 1 month 1 week Today

Company Information

Company NameIDL Biotech AB
Company Idea

"IDL Biotech AB (publ) är ett svenskt diagnostikföretag som utvecklar, producerar och marknadsför in vitro diagnostiska tester inom områdena onkologi och bakterologi."
CEOHans ÖrströmChairm. of the BoardLeif Pihlqvist
Phone08-799 67 50Fax08-799 93 20
Homepagehttp://www.idl.seE-mailidlbiotech(snabel-a)idl(punkt)se

Instrument Information

Full NameIDL Biotech BShort NameIDL B
No of shares27,338,189Ratio Value0.4 SEK
TypeShareISIN codeSE0000514747

Price Information

+/-0.00
%0.00
Latest0.77
High0.77
Low0.77
Volume6,799
Turnover (SEK)5,235
Market Cap (Mkr)21.1

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
1:39 PMSBNSBN0.77799
1:34 PMSBNSBN0.776,000

Scheduled Reports

DateReport
2013-05-29Årsstämma
2013-08-29Halvårsrapport
2013-10-24Delårsrapport tre
2014-02-27Bokslutskommuniké för 2013

Latest Movies and hearings

DateDescription




  • Danderydsgatan 10
  • 114 86 Stockholm
  • Telefon: 08 - 545 038 00
  • Fax: 08 - 611 35 62
  • info(snabel-a)aktietorget(punkt)se